- Five-year Outcomes of Ranibizumab in Neovascular Age-related Macular Degeneration: Real Life Clinical Experience
-
Ozkaya A, Alkin Z, Togac M, Ahmet S, Perente I, Taskapili
- KMID: 2390285
- Korean J Ophthalmol.
- 2017 Oct;31(5):424-430.
- doi: 10.3341/kjo.2016.0125
PURPOSE: To evaluate the outcomes of 5-year ranibizumab treatment in neovascular age-related macular degeneration (nAMD) in a single center and real life clinical setting. METHODS: The records of nAMD patients who... -
- CITED
-
- Close
- SHARE
-
- Close
